Trial Profile
An Exploratory Study to Evaluate the Safety of Brimonidine Intravitreal Implant in Patients With Retinitis Pigmentosa
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Brimonidine (Primary)
- Indications Retinitis pigmentosa
- Focus Therapeutic Use
- 05 Apr 2014 New trial record
- 09 Sep 2010
- 27 Aug 2009